LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4219 | 4267 | 0.9908 | 0.9890 |
MCF7 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4427 | 4267 | 1.0382 | 1.0428 |
MCF7 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4319 | 4267 | 1.0135 | 1.0155 |
MCF7 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4134 | 4267 | 0.9698 | 0.9664 |
MCF7 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4159 | 4267 | 0.9760 | 0.9736 |
MCF7 | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 1235 | 3486 | 4267 | 0.8179 | 0.7876 |
MCF7 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4036 | 4267 | 0.9475 | 0.9410 |
MCF7 | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4134 | 4267 | 0.9704 | 0.9669 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4352 | 4267 | 1.0209 | 1.0238 |
MCF7 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3931 | 4267 | 0.9231 | 0.9119 |
MCF7 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3734 | 4267 | 0.8768 | 0.8583 |
MCF7 | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 1235 | 2312 | 4267 | 0.5424 | 0.4204 |
MCF7 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1235 | 1972 | 4267 | 0.4623 | 0.2987 |
MCF7 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4452 | 4267 | 1.0429 | 1.0455 |
MCF7 | PD0325901 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2435 | 4267 | 0.5703 | 0.4603 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3207 | 4267 | 0.7514 | 0.7040 |
MCF7 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2274 | 4267 | 0.5332 | 0.4066 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1395 | 4267 | 0.3268 | 0.0695 |
MCF7 | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1371 | 4267 | 0.3216 | 0.0600 |
MCF7 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2830 | 4267 | 0.6631 | 0.5890 |
MCF7 | YM 201636 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4254 | 4267 | 0.9964 | 0.9952 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3247 | 4267 | 0.7619 | 0.7178 |
MCF7 | YM 201636 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2946 | 4267 | 0.6904 | 0.6255 |
MCF7 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1235 | 768 | 4267 | 0.1803 | -0.2331 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1063 | 4267 | 0.2495 | -0.0803 |